Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific's Rotablator Anticipated To Generate $15 mil. In Q4 Sales

This article was originally published in The Gray Sheet

Executive Summary

A limited reintroduction of Boston Scientific's original Rotablator rotational atherectomy device later this month is anticipated to generate $15 mil. in sales for the firm in the fourth quarter.

You may also be interested in...



Spectranetics Catheter Sales Benefiting From RotaLink Recall

Spectranetics placed 16 atherectomy lasers and saw sales of disposable coronary angioplasty catheters more than double in the third quarter, largely at the expense of Boston Scientific's RotaLink Plus atherectomy system, the company reported Nov. 30 at the BancBoston Robertson Stephens annual health care conference in New York City.

Spectranetics Catheter Sales Benefiting From RotaLink Recall

Spectranetics placed 16 atherectomy lasers and saw sales of disposable coronary angioplasty catheters more than double in the third quarter, largely at the expense of Boston Scientific's RotaLink Plus atherectomy system, the company reported Nov. 30 at the BancBoston Robertson Stephens annual health care conference in New York City.

PE Biosystems DNA Analyzer Demand, Strong Sales Boost Stock 26% In Q3

Continued strong demand for the ABI Prism 3700 DNA analyzer, order growth across a broad range of additional products and release of financial results ahead of some analysts' estimates contributed to a 25.9% jump in PE Biosystems' stock price during the third quarter.

Related Content

UsernamePublicRestriction

Register

MT012314

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel